curex semaglutide GLP-1 Reviews 2026 – Is It Worth Trying? Pricing, Results & Real User Feedback Meet @shedrx! Shed weight for

Given their glucose-lowering effects, GLP-1s have become standard of care for type 2 diabetes, supplanting other medication classes such as sulfonylureas.2 In 2023, GLP-1s represented 63% of diabetes spend, up from 38% in 2020.2 While diabetes GLP-1s will continue to account for a greater portion of spend compared to obesity, costs related to GLP-1s prescribed for obesity are expected to grow at a faster rate over the next 3 years

Vision changes Includes rare cases of NAION (non-arteritic anterior ischemic optic neuropathy) and nAMD (neovascular age-related macular degeneration)

So now, when those participants dont drop pounds, they drop out

doi: 10.1016/j.pcl.2009.07.002

What is GERD